BRAIN
	BREAST
	GASTROINTESTINAL
	GENITOURINARY
	GYNECOLOGICAL
	HEAD AND NECK
	LUNG

	0627 - PHASE II TRIAL OF DASATINIB IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME (Temporarily Closed)
	0320 - A PHASE III TRIAL COMPARING WHOLE brain RADIATION AND STEROTACTIC RADIOSURGERY ALONE VERSUS WITH TEMOZOLOMIDE OR ERLOTINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AND 1-3 BRAIN METASTASES
	0614 - A Randomized, Phase III, Double-Blind, Placebo-Controlled Trial of Memantine for Prevention of Cognitive Dysfunction in Patients Receiving Whole-Brain Radiotherapy

	B-39/0413 - A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer
	pacct-1 - Program for the Assessment of Clinical Cancer Tests (PACCT-1): Trial Assigning IndividuaLized Options for Treatment: The TAILORx Trial
	B-44-I (BETH) - A MULTICENTER PHASE III RANDOMIZED TRIAL OF ADJUVANT THERAPY FOR PATIENTS WITH HER2-POSITIVIE NODE NEGATIVE OR HIGH RISK NODE-NEGATIVE BREAST CANCER COMPARING CHEMOTHERAPY PLUS TRASTUZUMAB WITH CHEMOTHERAPY PLUS TRASTUZUMAB PLUS BEVACIZUMAB
	IBCSG 24-02 - A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women with Endocrine Responsive Breast Cancer (SOFT)
	B-43 - A PHASE III CLINICAL TRIAL COMPARING TRASTUZUMAB GIVEN CONCURRENTLY WITH RADIATION THERAPY AND RADIATION THERAPY ALONE FOR WOMEN WITH HER2-POSITIVE DUCTAL CARCINOMA IN SITU RESECTED BY LUMPECTOMY
	S0307 - Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer

40503 - Endocrine Therapy in Combination with Anti-VEGF Therapy: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Endocrine Therapy Alone or Endocrine Therapy Plus Bevacizumab (NSC704865; IND 7921) for Women with Hormone Receptor-Positive Advance Breast Cancer

0436 - A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who Are Treated Without Surgery

	80405 - A Phase III Trial of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum
	5202 - A Randomized Phase III Study Comparing 5-FU, Leucovorin and Oxaliplatin versus 5-FU, Leucovorin, Oxaliplatin and Bevacizumab in Patients with Stage II Colon Cancer at High Risk for Recurrence to Determine Prospectively the Prognostic Value of Molecular Markers Temp closed to accrual

RECTAL

	0822 - A PHASE II EVALUATION OF PREOPERATIVE CHEMORADIOTHERAPY UTILIZING INTENSITY MODULATED RADIATION THERAPY (IMRT) IN COMBINATION WITH CAPECITABINE AND OXALIPLATIN FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER
	r-04 - A Phase III Clinical Trial Comparing Preoperative Radiation Therapy and Capecitabine with Preoperative Radiation Therapy and Continuous Intravenous Infusion (CVI) of 5-Fluorouracil (5-FU) in the Treatment of Patients with Operable Carcinoma of the Rectum

Back to Top

E2805 -  A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma

	0518 - A Phase III, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Zometa® for the Prevention of Osteoporosis and Associated Fractures in Patients Receiving Radiation Therapy and Long Term LHRH Agonists for High-Grade and/or Locally Advanced Prostate Cancer
	S0421 - Phase III Study of Docetaxel and Atrasentan versus Docetaxel and Placebo for Patients with Advanced Hormone Refractory Prostate Cancer

	0514 - ESTABLISHMENT OF A HEAD AND NECK CANCER TISSUE/SPECIMEN REPOSITORY
	1305 - A Phase III Randomized Trial of Chemotherapy With or Without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
	0619 - A Randomized Phase II Trial of Chemoradiotherapy Versus Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head And Neck

	E1505 - a phase iii randomized trial of adjuvant chemotherapy with or without bevacizumab for patIents with completely resected stage ib (> 4 CM) -IIIA NON-SMALL CELL LUNG CANCER (NSCLC)
	0617 - A Randomized Phase III Comparison of Standard-Dose (60Gy) Versus High-Dose (74Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel In Patients with Stage IIIA/IIIB Non-Small Cell Lung Cancer